ADX-629 Therapy for Sjogren-Larsson Syndrome

计划入组 8 人 · 首次发布于 2022 年 7 月 5 日

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers

计划入组 20 人 · 首次发布于 2013 年 10 月 30 日

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

计划入组 11 人 · 首次发布于 2018 年 2 月 26 日

Sjogren's syndrome (Precisionlife)

Sjogren's syndrome(ImmuneID)

Leigh syndrome therapeutic(Leigh syndrome)

Larsson, Berit

Sweden

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

Aldeyra Therapeutics Advances Novel Therapies for Ocular and Systemic Immune-Mediated Diseases

Alcoholic Hepatitis Pipeline Insights 2024: Emerging Therapies and Market Prospects

Ainos Receives IRB Approval for Sjogren's Syndrome Clinical Study